Q. Uh, seven bestselling books … you could be retired on some private island … why are you here? A. It’s simple. I fell in love with IndieBio. I mean, I really love it. I’ve been deeply committed [...]
What factors drive innovation and supply chain disruption in the manufacture of medicines? What technologies will be critical over the next decade to increase access to vital medication and to [...]
IndieBio – now operating out of both San Francisco and New York – is proud to announce our new batches of startups. This is New York’s first batch, and San Francisco’s tenth. Though we are [...]
The large, systemic problems facing humanity have never been clearer, nor has the need for innovative biotech solutions for these problems. The new IndieBio New York program, launching May 2020, [...]
Announcement We are seeking up to 8 startups to receive a minimum of $250,000 each to pursue the development of diagnostics, therapeutics, vaccines, disinfection, and other solutions addressing [...]
IndieBio helps entrepreneurs build ground-breaking biotech companies. We’re excited to share our ninth class of 11 new startups. They have been here for thirty days, working tirelessly to derisk [...]
Beeline takes engineered immune cell therapy in a new direction. They are unique in how they have engineered regulatory T cells (Tregs), which play a natural role in ramping down the immune [...]
Gavilán Biodesign emerged out of the Donald Lab at Duke University, one of the world leaders in computational drug design. During their time at Duke, they redesigned many compounds, including a [...]
The CRISPR Cas complex has been a game-changing technology for gene editing. CASPR Biotech is using the incredible accuracy of CRISPR for something different — to revolutionize medical [...]
